Physician profile
Harry Pellman
NPI 1295771814
$39,524.68
in general payments reported to CMS, 2019-2025
13 companies · $5,544 in 2025
The $5,544 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $1,078 · 2021: $3,460 · 2022: $10K · 2023: $7,655 · 2024: $11K · 2025: $5,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Consulting Fee: $7,920 · Travel and Lodging: $2,244 · Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,119.00 |
| Consulting Fee | $7,920.00 |
| Travel and Lodging | $2,243.65 |
| Food and Beverage | $1,143.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $38,633.76 | 2019-2025 | |
| Glaxosmithkline, LLC. | $279.90 | 2019-2025 | Bexsero, Penmenvy |
| Merck Sharp & Dohme LLC | $228.41 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $75.86 | 2019 | |
| Cranial Technologies, INC | $61.43 | 2019-2025 | Doc Band |
| Sobi, INC | $52.16 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.23 | 2019-2020 | |
| Genentech, INC. | $38.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.83 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $22.82 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $22.59 | 2025 | Neffy |
| Genentech USA, INC. | $19.66 | 2019 | |
| Phadia US INC. | $19.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Pellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.